Skip to main content
logo
Canature Health Technology Co., Ltd. (SHE:300272)
China flag China · Delayed Price · Currency is CNY
6.23
+0.15 (2.47%)
Aug 14, 2026, 3:04 PM CST

SHE:300272 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
40.5256.0170.39132.4592.56104.86
Depreciation & Amortization
89.6189.6184.0676.9175.7652.12
Other Amortization
9.369.364.492.314.5711.6
Loss (Gain) From Sale of Assets
0.140.140.11-2.42-1.550.18
Asset Writedown & Restructuring Costs
0.090.090.080.0915.476.52
Loss (Gain) From Sale of Investments
43.7143.7122.46-5.13-3.74-35.38
Provision & Write-off of Bad Debts
2.882.881.262.360.552.78
Other Operating Activities
47.6794.9461.4845.5818.230.84
Change in Accounts Receivable
-3.74-3.74-8.07-4.7426.17-137.99
Change in Inventory
-45.69-45.69-13.162.38-37.84-65
Change in Accounts Payable
53.9353.9358.6662.6-39.9218.53
Change in Other Net Operating Assets
--18.631.640.30.47
Operating Cash Flow
236.84299.61292.05374.83155.44186.77
Operating Cash Flow Growth
-28.42%2.59%-22.09%141.15%-16.78%33.00%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-129.34-144.72-130.86-80.24-94.58-71.29
Sale of Property, Plant & Equipment
17.7216.950.140.572.644.7
Cash Acquisitions
----07.06
Divestitures
----8.43-99.88
Investment in Securities
47.84117.35-178.76-262.1127.12-41.03
Other Investing Activities
5.225.650.15-5.010.16
Investing Cash Flow
-58.3-4.5-309.07-349.67-59.81-0.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-1,3561,1621,124518.85409.78
Total Debt Issued
1,4391,3561,1621,124518.85409.78
Long-Term Debt Repaid
--981.14-1,211-643.52-357.88-427.33
Total Debt Repaid
-991.42-981.14-1,211-643.52-357.88-427.33
Net Debt Issued (Repaid)
447.43375.19-49.08480.69160.97-17.55
Issuance of Common Stock
---44.69-2.29
Repurchase of Common Stock
-9.68--29.06--31.37-38
Common Dividends Paid
-135.64-132.57-182.2-78.16-69.87-40.86
Other Financing Activities
-289.62-65.71-11.67-16.94-28.75-2.49
Financing Cash Flow
12.49176.91-272.01430.2930.98-96.6

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-27.35-14.8412.3420.4514.820.84
Net Cash Flow
163.69457.18-276.68475.9141.4390.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
107.5154.89161.19294.5960.85115.48
Free Cash Flow Growth
-40.83%-3.91%-45.28%384.12%-47.30%18.70%
Free Cash Flow Margin
5.82%8.41%9.35%17.62%3.66%7.64%
Free Cash Flow Per Share
0.180.270.280.510.110.20
Levered Free Cash Flow
50.34124.09160.65165.73107.38107.21
Unlevered Free Cash Flow
79.19152.13186.8183.5117.91117.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
5660.4761.9745.2218.4219.91
Change in Working Capital
2.872.8747.72122.68-46.3813.25